Medicament for treating post-traumatic pneumonia

A technology of pneumonia and drugs, applied in the field of drugs for the treatment of post-traumatic pneumonia, can solve the problems of increasing the burden of liver and kidney metabolism, insufficient lung ventilation, and unimproved primary factors of the lungs, so as to reduce the types and dosage of drugs and increase the Ventilation volume, the effect of increasing the burden on the liver and kidney

Inactive Publication Date: 2014-05-21
李倩
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the pathogenesis of post-traumatic pneumonia is quite different from that of ordinary pneumonia. Bacterial or mycoplasma invasion is only a subsequent manifestation. Convulsions and dehydration", purely treating the pathogenic microorganisms is only a palliative treatment. If the primary factors of the lungs do not improve, once the drug is stopped, it will relapse
And in the case of atelectasis and retention of bronchial secretions, in order to remove pathogenic microorganisms, it is necessary to increase the dose of antibiotics and increase the metabolic burden of liver and kidney after trauma

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] Example 1, the weight ratio of raw materials: 10g of Chuanshishi, 8g of the upper leaves of the fruit, 8g of Alicanthus, 6g of Usnea, 6g of golden buckwheat stems and leaves, 8g of Cuscuta, 6g of Tractoria vine, 8g of Angelica sinensis, and 3g of Mountain Ginger.

Embodiment 2

[0028] Example 2, the weight ratio of raw materials: 20g Chuanshishi, 15g upper fruit leaves, 15g Alicanthus, 10g Usnea, 10g golden buckwheat stems and leaves, 15g Cuscuta vine, 10g Tectonicus vine, 15g Angelica sinensis, 6g mountain ginger.

Embodiment 3

[0029] Example 3, the weight ratio of raw materials: 15g Chuanshishi, 10g upper leaves, 10g Alicanthus, 8g Usnea, 8g golden buckwheat stems and leaves, 10g Cuscuta vine, 8g Tractoria vine, 10g Angelica, and 5g Mountain Ginger.

[0030] When in use, decoct the traditional Chinese medicine Chuanchashi, Guoshangye, Aliteng, Usnea, Golden Buckwheat stems and leaves, Cuscuta, Trichumbra, Ginger, and Angelica twice with water, combine the filtrates, and take it in the morning and evening.

[0031] The effective combination and coordination of the above drugs can effectively achieve the purpose of treating post-traumatic pneumonia with less side effects. The above results are fully proved by the clinical data, and the relevant data are as follows, wherein the drug used in the study is the weight ratio of the bulk drug in Example 3.

[0032] 1 Objects and methods.

[0033] 1.1 Subject.

[0034] 1.1.1 Inclusion criteria: 100 cases of post-traumatic pneumonia from January 2003 to Sept...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a medicament for treating post-traumatic pneumonia, which is used for solving the treatment problem of post-traumatic pneumonia. The medicament is characterized by being processed by various Chinese medicinal herbs, and comprises the following raw materials in parts by weight: 10-20 parts of cudrania roots, 8-15 parts of herbs of dense flower bulbophyllum, 8-15 parts of alyxia sinensis, 6-10 parts of Chinese usnea, 6-10 parts of golden buckwheat rhizomes, 8-15 parts of cuscuta chinensis, 6-10 parts of Chinese starjasmine stems, 8-15 parts of angelica and 3-6 parts of alpinia japonica. Clinical experiments prove that the medicament for treating post-traumatic pneumonia disclosed by the invention has the characteristics of good curative effect and high safety, and is worthy of clinical application and promotion.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicine, in particular to a medicine for treating post-traumatic pneumonia. Background technique [0002] Post-traumatic pneumonia refers to various types of lung parenchymal inflammation caused by bacteria, fungi and other pathogens within 2 weeks after the trauma of the patient. Complications such as respiratory failure occur first after the operation, and the trachea is intubated, and then pneumonia occurs. Those who are classified as ventilator pneumonia and do not belong to the category of post-traumatic pneumonia. [0003] After trauma, hypoventilation of the lungs, poor diaphragmatic activity, impaired or inhibited cough reflex, bronchospasm and dehydration lead to retention of bronchial secretions, leading to segmental atelectasis and subsequent pulmonary infection. About 40% of posttraumatic pneumonia is a complication of rib fractures or chest trauma, but skull fractures or other hea...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/9062A61P11/00
Inventor 李倩
Owner 李倩
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap